FDA 510(k) Clearance — K212561

Substantial Equivalence Determination · U.S. Food & Drug Administration
K212561
MTX-C1 (TORR RF)
Electrosurgical Cutting & Coagulation (Class II)
21 CFR 878.4400
PBX
September 27, 2022
Substantially Equivalent (SESE)
Venus Legacy CX (K143554)
▼ View Original PDF (8 pages)
FDA 510(k) Letter

510(k) Clearance Letter

Page 1
Page 1
U.S. FDA — SUBSTANTIAL EQUIVALENCE DETERMINATION
Date
September 27, 2022
To
ILOODA Co., Ltd
% Dave Kim, Medical Device Regulatory Affairs
Mtech Group, 7505 Fannin St. Ste 610, Houston, TX 77054
Re
K212561
Trade/Device Name
Mtx-c1
Regulation Number
21 CFR 878.4400
Regulation Name
Electrosurgical Cutting And Coagulation Device And Accessories
Regulatory Class
Class II
Product Code
PBX
Dated
July 22, 2022
Received
August 1, 2022

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976. You may, therefore, market the device, subject to the general controls provisions of the Act.

Page 2
Page 2

Compliance Requirements

  • Registration and listing (21 CFR Part 807)
  • Labeling (21 CFR Part 801)
  • Medical device reporting (21 CFR Part 803)
  • Good manufacturing practice / Quality System (21 CFR Part 820)
  • Electronic product radiation control (Sections 531-542 of the Act)
  • 21 CFR 1000-1050

Signed By

Colin K. Chen, for Long Chen, Ph.D.
Assistant Director, DHT4A: Division of General Surgery Devices
OHT4: Office of Surgical and Infection Control Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health

Indications for Use (FDA Form 3881)

Page 3
Page 3
INDICATIONS FOR USE — FORM FDA 3881
510(k) Number
K212561
Device Name
MTX-C1
Indications
The MTX-C1 is intended for the treatment of the following medical condition; using three types of handpieces for delivery of non-thermal RF combined with massage:

• Relief of minor muscle aches and pain, relief of muscle spasm
• Temporary improvement of local blood circulation
• Temporary reduction in the appearance of cellulite
Type of Use
[✓] Prescription Use (Part 21 CFR 801 Subpart D)

Traditional 510(k) Summary — K212561

Page 4
Page 4

I. Submitter

SubmitterIlooda Co., Ltd
HQ Address120, Jangan-ro 458 Beon-gil, Jangan-Gu, Suwon-Si, Gyeonggido, KOREA 16200
ContactYun-Jung HA (yjha@ilooda.com) / RD Manager
Official CorrespondentDave Kim (davekim@mtech-inc.net)
7505 Fannin St, Suite 610, Houston, TX 77054

Proposed Device

Trade NameMTX-C1
Common NameElectrosurgical cutting and coagulation device and accessories
Regulation21 CFR 878.4400 (Product Code: PBX)
ClassClass II

Predicate Device

Trade NameVenus Legacy CX
510(k)K143554
Regulation21 CFR 878.4400 (Product Code: PBX)
ClassClass II

This predicate has not been subject to a design-related recall.

Page 5
Page 5

II. Device Description

The MTX-C1 main unit is a RF (Radio-frequency) energy generator employed for a variety of aesthetic applications. The Main unit output is set and monitored via touchscreen and controlled by a footswitch.

The system consists of:

  1. Main unit
  2. 3 type treatment handpiece (Small, Medium, Large)
  3. Footswitch
  4. Touch screen (User interface)

III. Indications for Use

  • Relief of minor muscle aches and pain, relief of muscle spasm
  • Temporary improvement of local blood circulation
  • Temporary reduction in the appearance of cellulite

Technological Comparison with Predicate Device

Page 6
Page 6
FeatureMTX-C1 (Proposed)Venus Legacy CX (Predicate)
ManufacturerIlooda Co., LtdVenus Concept Ltd., Weston FL, USA
510(k)K212561K143554
Product CodePBXPBX
Energy TypeRF energyRF energy
ComponentsMain unit + 3 handpieces (S/M/L) + Footswitch + Touch screenMain unit + 2 applicators (LB2/LF2) + Footswitch/finger switch + Touch screen
Frequency1 MHz ± 10%1 MHz ± 10%
Max Power55W @ medium/large, 7.5W @ smallUp to 150W
RF ModeBipolarBipolar
MaterialsBiocompatibleBiocompatible
Power100-240V~, 50/60Hz100-120 VAC / 60Hz, 220-240 VAC / 50Hz

Performance Data & Conclusions

Page 7
Page 7

V. Performance Data

Biocompatibility testing: Patient contact components and materials tested and validated according to ISO 10993-1. Identical to the predicate device.

Non-Clinical testing:

  • IEC 60601-1 — Basic safety and essential performance: Fulfilled
  • IEC 60601-1-2 — Electromagnetic compatibility: Fulfilled
  • IEC 60601-2-2 — HF surgical equipment: Fulfilled

Performance bench testing: Three handpieces tested to achieve superficial skin temperature (40-45°C) and maintain it for the required therapy time. Testing data demonstrated substantial equivalence to the predicate device.

VI. Conclusions

The intended use of the MTX-C1 is within the scope of the predicate device. MTX-C1 system, from both a design and clinical perspective, uses similar or identical technology as the cited predicate device and has the same intended uses.

Page 8
Page 8

Based upon the predicted overall performance characteristics for the MTX-C1, Ilooda Co., Ltd., believes that no significant differences exist in the usage of its underlying technological principles between MTX-C1 and the cited predicate device.